NantHealth, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 03, 2022 at 04:05 pm EDT
Share
NantHealth, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 16.63 million compared to USD 14.36 million a year ago. Net loss was USD 13.66 million compared to USD 10.84 million a year ago. Basic loss per share was USD 1.8 compared to USD 1.35 a year ago.
For the nine months, revenue was USD 49.5 million compared to USD 46.62 million a year ago. Net loss was USD 42.12 million compared to USD 41.55 million a year ago. Basic loss per share was USD 5.4 compared to USD 5.55 a year ago.
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Companyâs products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Companyâs subsidiary, helps businesses monitor and manage network health and performance.
NANTHEALTH, INC. 
